Assessing EGFR mutations
- PMID: 16452569
- DOI: 10.1056/NEJMc052564
Assessing EGFR mutations
Comment on
-
Erlotinib in lung cancer - molecular and clinical predictors of outcome.N Engl J Med. 2005 Jul 14;353(2):133-44. doi: 10.1056/NEJMoa050736. N Engl J Med. 2005. PMID: 16014883 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous